Professor Christopher Eden is invited as a guest expert to BBC Radio 4’s PM with Eddie Mair, and explains with evidence why PSA testing for prostate cancer in men aged 40 and above is so important. …
Professor Christopher Eden discusses the advent of Retzius-sparing robotic radical prostatectomy and how it is transforming continence rates in his patients….
Professor Eden shares the story of Mr. Steve Gregory and his successful Retzius-sparing robotic radical prostatectomy….
During the past year, I and the other surgeons at Santis have been increasingly using real-time, frozen-section analysis of the prostate during surgery to allow us to maximise nerve preservation without compromising on cancer control (i.e. removing the cancer). This is part of our drive to deliver better cancer and functional outcomes for patients than…
Introduction One of the commonest concerns voiced by patients contemplating having prostate cancer surgery is the prospect of having a catheter inserted in the penis for 1-2 weeks after the operation to drain urine while your bladder is healing from the operation. In this article I explain why this should not be something to fear,…
One year on from the UK’s first Retzius-sparing radical prostatectomy, Christopher Eden shares his findings: 3x better continence rate and happier patients….
Introduction In the last year or so, I’ve spent quite a bit of time writing about choosing a treatment for prostate cancer, and even more time writing about life after treatment in terms of nerve regeneration and continence. What isn’t often discussed is the actual operation itself, and the several weeks of recovery that follow…
Many of our patients have their prostate cancer diagnosed early, giving them an extremely high chance of a long-term cure with limited side effects, if any. Once they are diagnosed and they have come to terms with their condition, their mind soon turns to the best way to treat it. There is a lot of…
A recent publication in the Lancet of a randomised trial of 326 men (men were assigned randomly to either treatment to minimise biases) of open versus robotic surgery found that cancer control, continence and sexual function 3 months after surgery were similar in the two groups. So, what does this mean in practice? As is often…
One of the most difficult decisions for any man with prostate cancer is deciding what treatment would be best for them. Of course, they take advice from their urologist, but in my experience many also seek out information themselves, looking to established research and charities like Prostate Cancer UK for information on what treatments are…
© Santis Health Limited 2024. Registered in the UK under company number 10592044.